Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone

BJU International

Volumn 114, Issue 6, 2014, Pages E32-E42

  Rud, Erik ^a   Klotz, Dagmar ^a   Rennesund, Kristin ^b   Baco, Eduard ^b   Berge, Viktor ^b   Lien, Diep ^b   Svindland, Aud ^c   Lundeby, Eskild ^b   Berg, Rolf E ^b   Eri, Lars M ^b   Eggesbø, Heidi B ^d  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

diffusion weighted MRI; index tumour; MRI; prostate cancer; tumour volume

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SCOPOLAMINE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; T2 WEIGHTED IMAGING; TUMOR LOCALIZATION; TUMOR VOLUME; AGED; CANCER GRADING; COMPARATIVE STUDY; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL;

AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; TUMOR BURDEN;

EID: 84920091521     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12637     Document Type: Article

References (25)

1. Miller GJ, Cygan JM,. Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. J Urol 1994; 152: 1709-1713
2. Arora R, Koch MO, Eble JN, Ulbright TM, Li L, Cheng L,. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 2004; 100: 2362-2366
3. Turkbey B, Mani H, Shah V, etal. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011; 186: 1818-1824
4. Nishida S, Kinoshita H, Mishima T, Kurokawa H, Sakaida N, Matsuda T,. Prostate cancer detection by prebiopsy 3.0-Tesla magnetic resonance imaging. Int J Urol 2011; 18: 653-658
5. Delongchamps NB, Rouanne M, Flam T, etal. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 2010; 107: 1411-1418
6. Girouin N, Mège-Lechevallier F, Tonina Senes A, etal. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur Radiol 2006; 17: 1498-1509
7. Karavitakis M, Ahmed HU, Abel PD, Hazell S, Winkler MH,. Margin status after laparoscopic radical prostatectomy and the index lesion: implications for preoperative evaluation of tumor focality in prostate cancer. J Endourol 2012; 26: 503-508
8. Algaba F, Montironi R,. Impact of prostate cancer multifocality on its biology and treatment. J Endourol 2010; 24: 799-804
9. Wise AM, Stamey TA, McNeal JE, Clayton JL,. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 2002; 60: 264-269
10. Epstein JI,. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. J Urol 2011; 186: 790-797
11. van der Kwast TH, Amin MB, Billis A, etal. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 2011; 24: 16-25
12. Rud E, Baco E, Eggesbø HB,. MRI and ultrasound-guided prostate biopsy using soft image fusion. Anticancer Res 2012; 32: 3383-3389
13. Samaratunga H, Montironi R, True L, etal. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol 2011; 24: 6-15
14. Jonmarker S, Valdman A, Lindberg A, Hellström M, Egevad L,. Tissue shrinkage after fixation with formalin injection of prostatectomy specimens. Virchows Arch 2006; 449: 297-301
15. Turkbey B, Mani H, Aras O, etal. Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol 2012; 188: 1157-1163
16. Villers A, Puech P, Mouton D, Leroy X, Ballereau C, Lemaitre L,. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 2006; 176: 2432-2437
17. Bland JM, Altman DG,. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310
18. Perera M, Lawrentschuk N, Bolton D, Clouston D,. Comparison contemporary methods of estimating prostate tumor volume in pathological specimens. BJU Int 2014; 113: 29-34
19. Nakashima J, Tanimoto A, Imai Y, etal. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 2004; 64: 101-105
20. Lee DH, Koo KC, Lee SH, etal. Tumor lesion diameter on diffusion-weighted magnetic resonance image could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis. J Urol 2013; 190: 1213-1217
21. Delongchamps NB, Beuvon F, Eiss D, etal. Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer. Prostate Cancer Prostatic Dis 2011; 14: 232-237
22. Barentsz JO, Richenberg J, Clements R, etal. ESUR prostate MR guidelines 2012. Eur Radiol 2012; 22: 746-757
23. Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA,. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009; 30: 327-334
24. Kirkham APS, Emberton M, Allen C,. How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 2006; 50: 1163-1175
25. Mazaheri Y, Hricak H, Fine SW, etal. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 2009; 252: 449-457